The International Symposium of Gastrointestinal Oncology (ISGIO 2025) is dedicated to the latest advances in gastrointestinal (GI) cancer research, and critical issues in the care of people with GI cancer.
Topics
- Clinical trial readouts in the context of how testing for actionable genomic alterations should be implemented among patients with cancer
- Evidence supporting the use of biomarkers for risk stratification and prognostic assessment across cancer types
- Multidisciplinary decision-making in the assessment and application of genomic testing results along the cancer care continuum
- How specific genomic alterations and biomarkers can be leveraged to inform risk stratification and treatment planning in cancer
Who should Attend
Health professionals with an interest in GI oncology including:
- Oncologists and practitioners of oncology subspecialties
- Surgeons
- General scientists
- Radiologists
- Nurses
- Young investigators
- Pharmacists
